Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 454

Results For "MED"

6585 News Found

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya
News | April 25, 2022

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya

April 25th is commemorated as World Malaria Day


Doctors at Yashoda successfully treated advanced-stage laryngeal cancer
Biotech | April 25, 2022

Doctors at Yashoda successfully treated advanced-stage laryngeal cancer

Deputy Mayor from Addis Ababa (Ethiopia) battled out a rare laryngeal cancer at Yashoda Hospitals Hyderabad


Twenty eight companies commit to Rs 6000 crore at Global Ayush meet
News | April 23, 2022

Twenty eight companies commit to Rs 6000 crore at Global Ayush meet

The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


Novavax initiates Covid-19 booster study in adolescents in Phase 3 trial
Biotech | April 23, 2022

Novavax initiates Covid-19 booster study in adolescents in Phase 3 trial

Continuation of pediatric expansion in adolescents of PREVENT-19 Phase 3 trial will evaluate safety and immunogenicity of a booster dose


Covid-19 vaccine protection against hospitalization wanes
News | April 23, 2022

Covid-19 vaccine protection against hospitalization wanes

Kaiser Permanente finds the Pfizer Covid-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months


IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol
News | April 23, 2022

IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol

All the capex is being met through internal accruals only


Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK
Biotech | April 23, 2022

Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK

The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences


USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
Biotech | April 22, 2022

USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic